Daniel Calabrese

We have a post doc opening in the Calabrese Lab, please consider applying if interested in transplant immunology and lung injury! jobrxiv.org/job/university…

📢 A NEW #ISHLT Consensus Statement on the considerations for endpoints in #LungTransplantation clinical trials is now available. 📖💡🫁 Check out the top takeaways ⏬

Are you a recent/soon-to-be PhD graduate in immunology or a related field? Want to develop novel therapeutics for lung disease/lung transplantation? We are looking for postdoctoral fellow through the the UHN Canada Leads opportunity uhn.ca/corporate/Abou…. Please get in touch!

Novel autoantibodies linked to #CLAD. Elevated IgG anti-tropoelastin, SP-D, and thyroglobulin signal higher CLAD risk, while IgG anti-CENP-B & PM/SCL100 may offer protection. #LungTransplant #Autoantibodies @stephenjmdphd, @DanielVosoughi 🔗: jhltonline.org/article/S1053-…

Donation after circulatory death is an international standard, with strict ethical guidance. Shining light on individual encounters like these does not seem accretive to our national organ shortage. nytimes.com/2025/07/20/us/…

🎈Ventilation with low tidal volumes saves lives. “Low” tidal volumes are defined using predicted body weight (PBW) formulas - but these are biased to⏫ % of lung volume in some patients! New 📰 @LancetRespirMed @ucsfccm @ucjointcph #ARDS #CriticalCare #PrecisionMedicine

📣 REMINDER: 3️⃣ #ISHLTResearchGrants are accepting applications—further your research career by applying. The research grants cover topics related to: ❤️ #CardiogenicShock 🫁 Development of acellular Ex Vivo Lung Perfusion (#EVLP) technologies 🧬 #Biomarkers and #AI in #LungTX

Great piece by @nytimes showing the impact of broadly rescinding biomedical diversity grants. Many were awarded for a long distance traveled - "waking uphill barefoot in the snow," which directly effects rural constituents from all backgrounds. nytimes.com/2025/07/10/us/…

New article from Pulmonary Hypertension Association Registry on referrals for lung transplant. Only 18-29% with FC4, REVEAL Lite 2 high-risk, or 2022 ESC/ERS high-risk disease were referred for transplant. We need to do better with early referrals. sciencedirect.com/science/articl…

With @ParisTxGroup and @AlexandreLoupy, at #esot2025, we have officially announced the world’s FIRST AI TRANPLANT CLINIC that will be launched in 2026 ! It will be a revolution for precision diagnostics, prognostics, patient monitoring and therapeutic simulation ! #AI #Transplantation

A list of 17 total universities around the USA announcing layoffs or cuts from this week alone…

Love this targeted ad

Congratulations! Looking forward to working with @FrancescaLunar5 over the next year.

Thanks to all who attended the @ISHLT Research and Immunology networking event - we even had a surprise guest!

Thank you again to @TheJHLT for recognizing our work exploring the immune drivers of ALAD at #ISHLT2025! jhltonline.org/article/S1053-…

Fibrotic remodelling in chronic lung allograft dysfunction is associated with γδ T cells in bronchiolitis obliterans syndrome and intermediate M2 macrophages and Th1 cells in restrictive allograft syndrome. 🫁 🔗: jhltonline.org/article/S1053-…

Proud of the congressional leadership in California for leading the way to reform access to oxygen for patients with advanced lung disease. We need better access to liquid oxygen now. @RepDavidValadao @RepBrownley @atscommunity @CalThoracic valadao.house.gov/news/documents…

Excellent article on economic impacts of cutting US scientific funding @nytimes. Great example of how the study of something seemingly superfluous (microorganisms in Yellowstone hot springs) led to a vitally important breakthrough (Taq DNA polymerase). nytimes.com/2025/03/31/bus…

Duke Doctors Perform First Living Mitral Valve Transplant - ncmedsoc.org/duke-doctors-p…

Well that is extremely cool. PNAS article here: pnas.org/doi/10.1073/pn…